Works by Moulder, Stacy L.

Results: 28

Impact of TP53 mutations in Triple Negative Breast Cancer.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00303-6

By:

Mitri, Zahi I.;
Abuhadra, Nour;
Goodyear, Shaun M.;
Hobbs, Evthokia A.;
Kaempf, Andy;
Thompson, Alastair M.;
Moulder, Stacy L.

Publication type:

Article

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.

Published in:

2019

By:

Lim, Bora;
Murthy, Rashmi K.;
Lee, Jangsoon;
Jackson, Summer A.;
Iwase, Toshiaki;
Davis, Darren W.;
Willey, Jie S.;
Wu, Jimin;
Shen, Yu;
Tripathy, Debu;
Alvarez, Ricardo;
Ibrahim, Nuhad K.;
Brewster, Abenaa M.;
Barcenas, Carlos H.;
Brown, Powel H.;
Giordano, Sharon H.;
Moulder, Stacy L.;
Booser, Daniel J.;
Moscow, Jeffrey A.;
Piekarz, Richard

Publication type:

journal article

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.

Published in:

BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2788-x

By:

Hadad, Sirwan M.;
Jordan, Lee B.;
Roy, Pankaj G.;
Purdie, Colin A.;
Iwamoto, Takayuki;
Pusztai, Lajos;
Moulder-Thompson, Stacy L.;
Thompson, Alastair M.

Publication type:

Article

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers.

Published in:

NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00427-9

By:

Liu, Xuan;
Ge, Zhongqi;
Yang, Fei;
Contreras, Alejandro;
Lee, Sanghoon;
White, Jason B.;
Lu, Yiling;
Labrie, Marilyne;
Arun, Banu K.;
Moulder, Stacy L.;
Mills, Gordon B.;
Piwnica-Worms, Helen;
Litton, Jennifer K.;
Chang, Jeffrey T.

Publication type:

Article

A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis.

Published in:

NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0062-x

By:

Powell, Emily;
Shao, Jiansu;
Picon, Hector M.;
Bristow, Christopher;
Ge, Zhongqi;
Peoples, Michael;
Robinson, Frederick;
Jeter-Jones, Sabrina L.;
Schlosberg, Christopher;
Grzeskowiak, Caitlin L.;
Yang, Fei;
Wu, Yun;
Wistuba, Ignacio;
Moulder, Stacy L.;
Symmans, William F.;
Scott, Kenneth L.;
Edwards, John R.;
Liang, Han;
Heffernan, Timothy P.;
Piwnica-Worms, Helen

Publication type:

Article

High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07406-4

By:

Echeverria, Gloria V.;
Powell, Emily;
Seth, Sahil;
Ge, Zhongqi;
Carugo, Alessandro;
Bristow, Christopher;
Peoples, Michael;
Robinson, Frederick;
Qiu, Huan;
Shao, Jiansu;
Jeter-Jones, Sabrina L.;
Zhang, Xiaomei;
Ramamoorthy, Vandhana;
Cai, Shirong;
Wu, Wenhui;
Draetta, Giulio;
Moulder, Stacy L.;
Symmans, William F.;
Chang, Jeffrey T.;
Heffernan, Timothy P.

Publication type:

Article

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Published in:

2018

By:

Uemura, Marc I.;
French, John T.;
Hess, Kenneth R.;
Liu, Diane;
Raghav, Kanwal;
Hortobagyi, Gabriel N.;
Arun, Banu K.;
Valero, Vicente;
Ueno, Naoto T.;
Alvarez, Ricardo H.;
Woodward, Wendy A.;
Debeb, Bisrat G.;
Moulder, Stacy L.;
Lim, Bora;
Tripathy, Debu;
Ibrahim, Nuhad K.

Publication type:

journal article

Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.

Published in:

2015

By:

Bishop, Andrew J.;
Ensor, Joe;
Moulder, Stacy L.;
Shaitelman, Simona F.;
Edson, Mark A.;
Whitman, Gary J.;
Bishnoi, Sandra;
Hoffman, Karen E.;
Stauder, Michael C.;
Valero, Vicente;
Buchholz, Thomas A.;
Ueno, Naoto T.;
Babiera, Gildy;
Woodward, Wendy A.

Publication type:

journal article

Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

Published in:

Cancer (0008543X), 2014, v. 120, n. 14, p. 2164, doi. 10.1002/cncr.28701

By:

Hong, David S.;
Garrido‐Laguna, Ignacio;
Ekmekcioglu, Suhendan;
Falchook, Gerald S.;
Naing, Aung;
Wheler, Jennifer J.;
Fu, Siqing;
Moulder, Stacy L.;
Piha‐Paul, Sarina;
Tsimberidou, Apostolia M.;
Wen, YueJin;
Culotta, Kirk S.;
Anderes, Kenna;
Davis, Darren W.;
Liu, Wen;
George, Goldy C.;
Camacho, Luis H.;
Percy Ivy, Susan;
Kurzrock, Razelle

Publication type:

Article

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer.

Published in:

Cancer (0008543X), 2014, v. 120, n. 13, p. 1932, doi. 10.1002/cncr.28689

By:

Murthy, Rashmi K.;
Varma, Ankur;
Mishra, Priyankana;
Hess, Kenneth R.;
Young, Elliana;
Murray, James L.;
Koenig, Kimberly H.;
Moulder, Stacy L.;
Melhem‐Bertrandt, Amal;
Giordano, Sharon H.;
Booser, Daniel;
Valero, Vicente;
Hortobagyi, Gabriel N.;
Esteva, Francisco J.

Publication type:

Article

Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.

Published in:

2018

By:

Murthy, Rashmi K.;
Raghavendra, Akshara S.;
Hess, Kenneth R.;
Takeo Fujii;
Lim, Bora;
Barcenas, Carlos H.;
Hong Zhang;
Chavez-Mac-Gregor, Mariana;
Mittendorf, Elizabeth A.;
Litton, Jennifer K.;
Giordano, Sharon H.;
Thompson, Alastair M.;
Valero, Vicente;
Moulder, Stacy L.;
Tripathy, Debu;
Ueno, Naoto T.;
Fujii, Takeo;
Zhang, Hong

Publication type:

journal article

Does the PI3K Pathway Play a Role in Basal Breast Cancer?

Published in:

Clinical Breast Cancer, 2010, v. 10, p. S66, doi. 10.3816/CBC.2010.s.014

By:

Moulder, Stacy L.

Publication type:

Article

Novel Cytotoxic Backbones and Targeted Therapies: Recent Data and Ongoing Clinical Trials.

Published in:

Clinical Breast Cancer, 2010, v. 10, p. S30, doi. 10.3816/CBC.2010.s.010

By:

Moulder, Stacy L.

Publication type:

Article

Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors.

Published in:

2020

By:

Guo, Hua;
Ding, Qingqing;
Gong, Yun;
Gilcrease, Michael Z.;
Zhao, Min;
Zhao, Jun;
Sui, Dawen;
Wu, Yun;
Chen, Hui;
Liu, Hui;
Zhang, Jinxia;
Resetkova, Erika;
Moulder, Stacy L.;
Wang, Wei-Lien;
Huo, Lei

Publication type:

journal article

A Randomized Phase 2 Trial Comparing 3-Hour Versus 96-Hour Infusion Schedules of Paclitaxel for the Treatment of Metastatic Breast Cancer.

Published in:

Cancer (0008543X), 2010, v. 116, n. 4, p. 814, doi. 10.1002/cncr.24870

By:

Moulder, Stacy L.;
Holmes, Frankie A.;
Tolcher, Anthony W.;
Thall, Peter;
Broglio, Kristine;
Valero, Vicente;
Buzdar, Aman U.;
Arbuck, Susan G.;
Seidman, Andrew;
Hortobagyi, Gabriel N.

Publication type:

Article

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer.

Published in:

Oncologist, 2018, v. 23, n. 11, p. 1300, doi. 10.1634/theoncologist.2017-0498

By:

Basho, Reva K.;
Yam, Clinton;
Gilcrease, Michael;
Murthy, Rashmi K.;
Helgason, Thorunn;
Karp, Daniel D.;
Meric‐Bernstam, Funda;
Hess, Kenneth R.;
Valero, Vicente;
Albarracin, Constance;
Litton, Jennifer K.;
Chavez‐MacGregor, Mariana;
Hong, David;
Kurzrock, Razelle;
Hortobagyi, Gabriel N.;
Janku, Filip;
Moulder, Stacy L.

Publication type:

Article

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.

Published in:

Oncologist, 2017, v. 22, n. 9, p. 1086, doi. 10.1634/theoncologist.2017-0095

By:

Yam, Clinton;
Mani, Sendurai A.;
Moulder, Stacy L.

Publication type:

Article

Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.

Published in:

Oncologist, 2017, v. 22, n. 4, p. 394, doi. 10.1634/theoncologist.2016-0307

By:

Candelaria, Rosalind P.;
Bassett, Roland L.;
Symmans, William Fraser;
Ramineni, Maheshwari;
Moulder, Stacy L.;
Kuerer, Henry M.;
Thompson, Alastair M.;
Yang, Wei Tse

Publication type:

Article

Multiple gene aberrations and breast cancer: lessons from super-responders.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1439-y

By:

Wheler, Jennifer J.;
Atkins, Johnique T.;
Janku, Filip;
Moulder, Stacy L.;
Yelensky, Roman;
Stephens, Philip J.;
Kurzrock, Razelle

Publication type:

Article

Multiple gene aberrations and breast cancer: lessons from super-responders.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 442, doi. 10.1186/s12885-015-1439-y

By:

Wheler, Jennifer J.;
Atkins, Johnique T.;
Janku, Filip;
Moulder, Stacy L.;
Yelensky, Roman;
Stephens, Philip J.;
Kurzrock, Razelle

Publication type:

Article

Multiple gene aberrations and breast cancer: lessons from super-responders.

Published in:

2015

By:

Wheler, Jennifer J;
Atkins, Johnique T;
Janku, Filip;
Moulder, Stacy L;
Yelensky, Roman;
Stephens, Philip J;
Kurzrock, Razelle

Publication type:

journal article

(S046) Prognosis for Patients With Metastatic Breast Cancer Who Achieve 'No-Evidence-of-Disease' Status After Systemic or Local Therapy.

Published in:

Oncology (08909091), 2015, v. 29, p. 1

By:

Bishop, Andrew J.;
Ensor, Joe;
Moulder, Stacy L.;
Shaitelman, Simona F.;
Edson, Mark A.;
Whitman, Gary J.;
Bishnoi, Sandra;
Hoffman, Karen E.;
Stauder, Michael C.;
Valero, Vicente;
Buchholz, Thomas A.;
Ueno, Naoto T.;
Babiera, Gildy;
Woodward, Wendy A.

Publication type:

Article

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.

Published in:

Investigational New Drugs, 2021, v. 39, n. 2, p. 509, doi. 10.1007/s10637-020-00995-2

By:

Yam, Clinton;
Rauch, Gaiane M.;
Rahman, Tanbin;
Karuturi, Meghan;
Ravenberg, Elizabeth;
White, Jason;
Clayborn, Alyson;
McCarthy, Pamela;
Abouharb, Sausan;
Lim, Bora;
Litton, Jennifer K.;
Ramirez, David L.;
Saleem, Sadia;
Stec, James;
Symmans, W. Fraser;
Huo, Lei;
Damodaran, Senthil;
Sun, Ryan;
Moulder, Stacy L.

Publication type:

Article

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.

Published in:

Investigational New Drugs, 2019, v. 37, n. 2, p. 345, doi. 10.1007/s10637-018-0700-z

By:

Yam, Clinton;
Esteva, Francisco J.;
Patel, Miral M.;
Raghavendra, Akshara S.;
Ueno, Naoto T.;
Moulder, Stacy L.;
Hess, Kenneth R.;
Shroff, Girish S.;
Hodge, Silvia;
Koenig, Kimberly H.;
Chavez Mac Gregor, Mariana;
Griner, Robin L.;
Yeung, Sai-Ching J.;
Hortobagyi, Gabriel N.;
Valero, Vicente

Publication type:

Article

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.

Published in:

Investigational New Drugs, 2018, v. 36, n. 6, p. 1103, doi. 10.1007/s10637-018-0672-z

By:

Yam, Clinton;
Murthy, Rashmi K.;
Rauch, Gaiane M.;
Murray, James L.;
Walters, Ronald S.;
Valero, Vicente;
Brewster, Abenaa M.;
Bast, Robert C.;
Booser, Daniel J.;
Giordano, Sharon H.;
Esteva, Francisco J.;
Yang, Wei;
Hortobagyi, Gabriel N.;
Moulder, Stacy L.;
Arun, Banu

Publication type:

Article

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Published in:

Investigational New Drugs, 2018, v. 36, n. 2, p. 299, doi. 10.1007/s10637-018-0564-2

By:

Yam, Clinton;
Murthy, Rashmi K.;
Valero, Vicente;
Szklaruk, Janio;
Shroff, Girish S.;
Stalzer, Carol J.;
Buzdar, Aman U.;
Murray, James L.;
Wei Yang;
Hortobagyi, Gabriel N.;
Moulder, Stacy L.;
Arun, Banu

Publication type:

Article

Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).

Published in:

Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 227, doi. 10.1007/s10549-018-05081-z

By:

Baez-Vallecillo, Luis;
Raghavendra, Akshara S.;
Hess, Kenneth R.;
Barcenas, Carlos H.;
Moulder, Stacy L.;
Tripathy, Debu;
Valero, Vicente;
Murthy, Rashmi K.

Publication type:

Article

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26019-y

By:

Clark, Amy S.;
Yau, Christina;
Wolf, Denise M.;
Petricoin, Emanuel F.;
van 't Veer, Laura J.;
Yee, Douglas;
Moulder, Stacy L.;
Wallace, Anne M.;
Chien, A. Jo;
Isaacs, Claudine;
Boughey, Judy C.;
Albain, Kathy S.;
Kemmer, Kathleen;
Haley, Barbara B.;
Han, Hyo S.;
Forero-Torres, Andres;
Elias, Anthony;
Lang, Julie E.;
Ellis, Erin D.;
Yung, Rachel

Publication type:

Article